{"id":6799,"date":"2021-06-03T07:14:40","date_gmt":"2021-06-03T07:14:40","guid":{"rendered":"https:\/\/ncrfrontlinenews.com\/?p=6799"},"modified":"2021-06-03T07:14:40","modified_gmt":"2021-06-03T07:14:40","slug":"after-pfizer-serum-institute-seeks-indemnity-over-covid-19-vaccine-sources","status":"publish","type":"post","link":"https:\/\/ncrfrontlinenews.com\/?p=6799","title":{"rendered":"After Pfizer, Serum Institute seeks indemnity over COVID-19 vaccine: Sources"},"content":{"rendered":"<p>New Delhi: Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the Serum Institute of India (SII) has also sought protection against liabilities, sources said on Thursday.<\/p>\n<p>Not just Serum Institute of India, all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted the same,\u201d sources added. Earlier last year, SII CEO Adar Poonawala had advocated for indemnity for all vaccine manufacturers.<\/p>\n<p>\u201cWe need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits\u2026 Frivolous claims come up and you see in the media something being blown out of proportion. The government needs to step in with the right messaging,\u201d he had said.<\/p>\n<p>Amid the nationwide COVID-19 vaccine crunch, US pharma giant Pfizer is seeking an indemnity bond that will exempt it from legal claims in case there are any adverse effects from the vaccine.<\/p>\n<p>NITI Aayog Member (Health) Dr VK Paul had said on May 27 that the government is still examining the American pharma company\u2019s request for indemnity.<\/p>\n<p>\u201cWe are examining this request and will make a decision in the larger interest of people and on merit. This is under discussion and there is no decision as of now,\u201d he had said.<\/p>\n<p>No company in India\u2019s vaccination history has ever paid indemnity and the government, which is the biggest user of vaccines, has also not done it, Dr Nirmal K Ganguly, former ICMR chief had said on Wednesday.<\/p>\n<p>The Drugs Controller General of India (DCGI) had earlier exempted specific trials of COVID-19 vaccines that have been approved by some other international regulatory bodies. This is likely to clear the way of foreign COVID-19 vaccines such as Pfizer and Moderna.<\/p>\n<p>DCGI Chief VG Somani said in a letter that the decision will be applicable for vaccines that have already been approved for restricted use by the US FDA, EMA, UK MHRA, PMDA Japan or listed for Emergency Use by the World Health Organisation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>New Delhi: Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the Serum Institute of India (SII) has also sought protection against liabilities, sources said on Thursday. Not just Serum Institute of India, all the vaccine companies should get indemnity protection against liabilities if foreign [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6800,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"post-6799","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business"},"_links":{"self":[{"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/posts\/6799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6799"}],"version-history":[{"count":1,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/posts\/6799\/revisions"}],"predecessor-version":[{"id":6801,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/posts\/6799\/revisions\/6801"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/media\/6800"}],"wp:attachment":[{"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}